Related references
Note: Only part of the references are listed.Association between postoperative hypoalbuminemia and postoperative pulmonary imaging abnormalities patients undergoing craniotomy for brain tumors: a retrospective cohort study
Da-wei Zhao et al.
SCIENTIFIC REPORTS (2022)
Infection profiles of different chemotherapy regimens and the clinical feasibility of antimicrobial prophylaxis in patients with DLBCL
Akihiro Ohmoto et al.
BLOOD REVIEWS (2021)
Incidence and risk factors of pneumonia in diffuse large B-cell lymphoma patients receiving first line R-CHOP/R-CHOP-like immunochemotherapy: a retrospective study of 287 patients in single center
Jingwen Wang et al.
ANNALS OF PALLIATIVE MEDICINE (2021)
Prognostic Value of Peripheral Blood Lymphocyte/monocyte Ratio in Lymphoma
Feiqiong Gao et al.
JOURNAL OF CANCER (2021)
Interactions between life expectancy and the incidence and mortality rates of cancer in China: a population-based cluster analysis
Xiuying Gu et al.
CANCER COMMUNICATIONS (2018)
Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma
Claire Dendle et al.
SCIENTIFIC REPORTS (2017)
Incidence of intensive care unit admission, outcome and post intensive care survival in patients with diffuse large B-cell lymphoma
Philipp Wohlfarth et al.
LEUKEMIA & LYMPHOMA (2016)
Colony-Stimulating Factors for Febrile Neutropenia during Cancer Therapy
Charles L. Bennett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Risk Prediction Measures for Case-Cohort and Nested Case-Control Designs: An Application to Cardiovascular Disease
Andrea Ganna et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2012)
Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphoma
Ruth Pettengell et al.
SUPPORTIVE CARE IN CANCER (2012)
Tolerability and safety of rituximab (MabThera®)
E Kimby
CANCER TREATMENT REVIEWS (2005)
Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas
M Cullen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Presentation of multivariate data for clinical use: The Framingham Study risk score functions
LM Sullivan et al.
STATISTICS IN MEDICINE (2004)
Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma
GH Lyman et al.
CANCER (2003)
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
B Coiffier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)